Lampalizumab (Anti-Complement Factor D)

Ask supplier a question | View on supplier's website

Lampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2535
Sku #	A2535-1mg*5
Pricing	1mg*5, $1690.00

Feedback